Novo Nordisk's Wegovy has received accelerated approval for use in patients with metabolic dysfunction-associated ...

New NHS data suggests weight-loss jabs like Mounjaro could reduce sick days by a third and save taxpayers £5bn a year. But ...

Over 2,000 Ozempic and Zepbound lawsuits allege life-threatening side effects as FDA updates warnings and courts weigh ...

THE NHS is set to dish out Mounjaro prescriptions to more patients, as private clinics prepare to double their prices from ...

The company said Friday that it received FDA approval for a new Wegovy indication as a treatment of a fatty liver disease known as metabolic dysfunction-associated steatohepatitis, or MASH, in adults ...

Novo Nordisk shares climbed in premarket trading Monday after the U.S. Food and Drug Administration granted accelerated ...

Dr Donald Grant, GP and Senior Clinical Advisor at The Independent Pharmacy, warned it is 'crucial' to transition under ...

The company said it was reviewing Mounjaro pricing with other governments and expected to make similar adjustments in certain ...

A study of 421 patients on weight-loss treatments found people on the drugs took a third fewer days off because of ill health ...

Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...

As Mounjaro doubles in price, we look at whether there’s another, cheaper way to suppress your appetite. By nutritionist ...